The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Share News (MERC)

Share Price Information for Mercia Asset (MERC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.80
Bid: 32.00
Ask: 33.60
Change: 0.10 (0.31%)
Spread: 1.60 (5.00%)
Open: 32.70
High: 32.80
Low: 32.50
Prev. Close: 32.70
MERC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Mercia Technologies Makes Loss As Operations Ramped Up

Thu, 30th Jun 2016 11:57

LONDON (Alliance News) - Early-stage investor Mercia Technologies PLC on Wednesday said it made a loss in the year to the end of March as it ramped up its operations and invested in new businesses.

Mercia said it swung to a pretax loss of GBP1.7 million in the year to the end of March. The comparative figures provided by the company related to the period between Mercia's admission to London's AIM market in December 2014 to the end of March 2015. In that period, it made a GBP2.0 million profit, buoyed by fair value gains on its investment portfolio.

The loss for the 2015 financial year was driven by costs related to the headcount increase at the company as it scaled up its operations.

Mercia said it made revenue of GBP1.8 million in the 2016 financial year and said the value of its direct investment portfolio grew to GBP38.1 million from GBP24.6 million. Net fair value gains on the portfolio only amounted to GBP900,000 in the year, however, compared to GBP3.9 million in the prior three-and-a-half-month period.

Over the course of the financial year, Mercia invested GBP12.6 million in 16 companies, including Impression Technologies, Edge Case Games, Intelligent Positioning and Oxford Genetics.

"Mercia Technologies has made significant progress in the year under review. Our existing portfolio of direct investments is well balanced, having completed a number of both new and follow-on direct investments. Furthermore, we have put in place the foundations to accelerate our growth in the months and years ahead," said Mercia Chief Executive Mark Payton.

Mercia shares were untraded on Thursday, having last traded at 41.90 pence.

By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
19 Oct 2020 17:57

IN BRIEF: Mercia Asset Management Exits Clear Review Investment

IN BRIEF: Mercia Asset Management Exits Clear Review Investment

Read more
7 Oct 2020 18:20

UK TRADING UPDATE SUMMARY: Gym Group Fighting Fit With Fresh York Unit

UK TRADING UPDATE SUMMARY: Gym Group Fighting Fit With Fresh York Unit

Read more
25 Sep 2020 13:17

UK DIRECTOR DEALINGS SUMMARY: Founder Dunkerton Buys More Superdry

UK DIRECTOR DEALINGS SUMMARY: Founder Dunkerton Buys More Superdry

Read more
24 Sep 2020 17:35

UK TRADING UPDATE SUMMARY: Personal Group Lauds Royal Mail Contract

UK TRADING UPDATE SUMMARY: Personal Group Lauds Royal Mail Contract

Read more
18 Sep 2020 19:00

IN BRIEF: Mercia Asset Management Hails Life Sciences Sector

IN BRIEF: Mercia Asset Management Hails Life Sciences Sector

Read more
21 Jul 2020 19:02

IN BRIEF: Mercia Asset Management Leads Locate Bio Fundraise

IN BRIEF: Mercia Asset Management Leads Locate Bio Fundraise

Read more
14 Jul 2020 16:29

Mercia Asset Management Sinks To Annual Loss But Primed For Growth

Mercia Asset Management Sinks To Annual Loss But Primed For Growth

Read more
10 Jul 2020 15:10

CORRECT (July 9): Mercia Sells Native Antigen Stake For GBP4.8 Million

CORRECT (July 9): Mercia Sells Native Antigen Stake For GBP4.8 Million

Read more
9 Jul 2020 18:07

IN BRIEF: Mercia Sells Stake In Native Antigen For Up To GBP18 Million

IN BRIEF: Mercia Sells Stake In Native Antigen For Up To GBP18 Million

Read more
9 Jul 2020 09:13

Mercia to cash in on sale of the Native Antigen Company

(Sharecast News) - Regionally-focussed Mercia Asset Management announced the sale of the Native Antigen Company (NAC) on Thursday, to life sciences tools company LGC, for total cash of up to £18m.

Read more
1 Jul 2020 16:36

IN BRIEF: Mercia Asset Management's MIP Raises GBP5 Million

IN BRIEF: Mercia Asset Management's MIP Raises GBP5 Million

Read more
14 May 2020 17:13

UK TRADING UPDATE SUMMARY: Byotrol Sees Continuation Of Strong Demand

UK TRADING UPDATE SUMMARY: Byotrol Sees Continuation Of Strong Demand

Read more
6 May 2020 16:57

Mercia Asset Management Invests GBP1 Million In Biologics Firm Oxgene

Mercia Asset Management Invests GBP1 Million In Biologics Firm Oxgene

Read more
3 Apr 2020 14:26

Mercia Investee Northern Venture Capital Trusts Raises GBP38 Million

Mercia Investee Northern Venture Capital Trusts Raises GBP38 Million

Read more
2 Apr 2020 16:02

UK TRADING UPDATE SUMMARY: M&C Saatchi Feels Virus Pain

UK TRADING UPDATE SUMMARY: M&C Saatchi Feels Virus Pain

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.